Rhenman & Partners Asset Management AB - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 132 filers reported holding NOVOCURE LTD in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2023$2,620,800
+2.1%
45,000
+28.6%
0.29%
+7.5%
Q4 2022$2,567,250
+3.8%
35,0000.0%0.27%
+3.5%
Q3 2022$2,473,000
-40.7%
35,000
-41.7%
0.26%
-45.4%
Q2 2022$4,170,000
-27.8%
60,000
-13.9%
0.47%
-16.8%
Q1 2022$5,775,000
-39.9%
69,700
-42.1%
0.57%
-10.8%
Q4 2021$9,610,000
+37.9%
120,387
+100.6%
0.64%
+30.7%
Q3 2021$6,970,000
-73.8%
60,000
-50.0%
0.49%
-72.9%
Q2 2021$26,618,000
+11.9%
120,000
-33.3%
1.81%
+8.9%
Q1 2021$23,792,000
+14.6%
180,000
+50.0%
1.66%
-2.1%
Q4 2020$20,765,000
-54.5%
120,000
-70.7%
1.69%
-58.2%
Q3 2020$45,593,000
+105.0%
409,600
+9.2%
4.05%
+68.8%
Q2 2020$22,238,000
-8.3%
375,000
+4.2%
2.40%
-29.3%
Q1 2020$24,242,000
-17.8%
360,000
+2.9%
3.40%
+5.1%
Q4 2019$29,495,000
+16.0%
350,000
+2.9%
3.23%
+1.4%
Q3 2019$25,425,000
+9.9%
340,000
-7.1%
3.19%
+25.1%
Q2 2019$23,136,000
+5.6%
365,899
-19.5%
2.55%
-0.5%
Q1 2019$21,900,000
+20.0%
454,647
-16.6%
2.56%
+22.8%
Q4 2018$18,247,000
-12.9%
545,000
+36.2%
2.09%
-0.7%
Q3 2018$20,960,000
+48.8%
400,000
-11.1%
2.10%
+45.6%
Q2 2018$14,085,000
+48.5%
450,000
+3.4%
1.44%
+23.4%
Q1 2018$9,483,000
+0.4%
435,000
-7.0%
1.17%
-8.4%
Q4 2017$9,445,000
-28.6%
467,569
-29.9%
1.28%
-24.5%
Q3 2017$13,231,000
-37.1%
666,528
-45.2%
1.69%
-44.1%
Q2 2017$21,042,0001,216,3143.02%
Other shareholders
NOVOCURE LTD shareholders Q1 2018
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders